Type 3 fimbriae play a crucial role in Klebsiella pneumoniae biofilm formation, but the mechanism of the regulation of the type 3 fimbrial operon is largely unknown. In K. pneumoniae CG43, three regulatory genes, mrkH, mrkI and mrkJ, are located downstream of the type 3 fimbrial genes mrkABCDF. The production of the major pilin MrkA is abolished by the deletion of mrkH or mrkI but slightly increased by the deletion of mrkJ. Additionally, quantitative RT-PCR and a promoterreporter assay of mrkHI verified that the transcription of mrkHI was activated by MrkI, suggesting autoactivation of mrkHI transcription. In addition, sequence analysis of the mrkH promoter region revealed a putative ferric uptake regulator (Fur) box. Deletion of fur decreased the transcription of mrkH, mrkI and mrkA. The expression of type 3 fimbriae and bacterial biofilm formation were also reduced by the deletion of fur. Moreover, a recombinant Fur was found to be able to bind both promoters, with higher affinity for P mrkH than P mrkA , implying that Fur controls type 3 fimbriae expression via MrkHI. We also proved that iron availability can influence type 3 fimbriae activity.
INTRODUCTION
Klebsiella pneumoniae, an important nosocomial pathogen, causes a wide range of opportunistic infections, including pneumonia, bacteraemia, urinary tract infection and lifethreatening septic shock (Keynan & Rubinstein, 2007; Podschun & Ullmann, 1998) . The emergence of an invasive form of community-acquired K. pneumoniae infection, which presents as primary bacteraemic liver abscesses, endophthalmitis and meningitis, has been reported in Asia, especially Taiwan (Tsai et al., 2008) . Multiple-drugresistant K. pneumoniae, including extended-spectrum blactamase-and carbapenemase-producing strains, have been increasingly observed (Hirsch & Tam, 2010; Nordmann et al., 2009) . Studies of the pathogenic mechanisms of this organism are therefore necessary to identify novel targets for antibacterial agents.
The reported virulence factors of K. pneumoniae include capsular polysaccharide (CPS), lipopolysaccharide, iron-acquisition systems and fimbriae (Brisse et al., 2009; Podschun & Ullmann, 1998) . Fimbriae (or pili) help bacterial pathogens adhere to host cells for successful infection. In K. pneumoniae, type 1 and type 3 fimbriae are well characterized in the chaperone-usher assembly class (Fronzes et al., 2008) . Type 1 fimbriae, found in virtually all members of the family Enterobacteriaceae, can bind to mannose-containing structures on host cells or the extracellular matrix (Hanson et al., 1988; Klemm & Schembri, 2000) . They have also been shown to play a critical role in urinary tract infection by mediating adhesion to the uroepithelium (Rosen et al., 2008; Struve et al., 2008) . Type 3 fimbriae, originally characterized in Klebsiella strains, can cause mannose-resistant agglutination of tannic acid-treated human erythrocytes. The adhesion filaments encoded by the mrkABCDF operon (Huang et al., 2009) can reportedly adhere to epithelial cells from the respiratory and urinary tracts as well as to the extracellular matrix proteins collagen IV and V (Hornick et al., 1992; Jagnow & Clegg, 2003; Tarkkanen et al., 1997) . The role of type 3 fimbriae in biofilm formation of K. pneumoniae has also been repeatedly demonstrated (Di Martino et al., 2003; Jagnow & Clegg, 2003; Schroll et al., 2010; Struve et al., 2009 ).
The analysis of available genome sequences of K. pneumoniae has revealed three regulatory genes (mrkH, mrkI and mrkJ) downstream of the type 3 fimbrial genes (Johnson & Clegg, 2010) . MrkH, a PilZ domain protein, can bind to the second messenger bis-(39-59)-cyclic dimeric GMP (c-di-GMP) (Johnson et al., 2011) , and MrkI is predicted to be a LuxR-type transcriptional factor (Johnson & Clegg, 2010; Johnson et al., 2011) . Recent reports have shown that MrkH and MrkI positively regulate the expression of type 3 fimbriae (Johnson et al., 2011) , whereas MrkJ, a c-di-GMP phosphodiesterase (PDE), reduces that expression (Johnson & Clegg, 2010) .
In many bacteria, Fur generally regulates genes responsible for the uptake and metabolism of iron. Not only is Fur involved in regulating iron homeostasis but it also participates in bacterial colonization, the oxidative stress response, toxin secretion and virulence (Carpenter et al., 2009) . Under iron-replete conditions, Fur binds to iron and the Fe 2+ -Fur dimers bind to a 19 bp consensus DNA sequence, the Fur box (GATAATGATwATCATTATC; w5A or T), in target promoters (Baichoo & Helmann, 2002; Escolar et al., 1999) . The binding of Fur at the promoters impedes the binding of RNA polymerase, thereby preventing transcription from these genes. In some cases, however, Fur functions as an activator that may even regulate certain genes in the absence of iron (Carpenter et al., 2009 ).
Using K. pneumoniae CG43, a heavy encapsulated K2 isolate (Chang et al., 1996) , we investigated the regulatory role of MrkH, MrkI and MrkJ by generating specific gene-deletion mutants and analysing their effects on type 3 fimbriae expression. We also studied whether Fur and extracellular iron level influence the expression of type 3 fimbriae.
METHODS
Plasmids, bacterial strains and growth conditions. The bacterial strains and plasmids used in this study are listed in Table 1 . Escherichia coli and K. pneumoniae CG43 (Chang et al., 1996) and its derivatives were propagated at 37 uC in Luria-Bertani (LB) broth or M9 minimal medium. The antibiotics used included ampicillin (100 mg ml 21 ), kanamycin (25 mg ml 21 ), tetracycline (12.5 mg ml 21 ) and streptomycin (500 mg ml 21 ). Primers used in this study are listed in Table 2 . plasmids. Specific deletions were individually introduced into the chromosome of K. pneumoniae CG43S3 using an allelic exchange strategy (Lai et al., 2003) . The pKAS46 suicide plasmid was used in the selection of the mutants (Skorupski & Taylor, 1996) , and the mutations were confirmed with PCR. The resulting mutant strains are listed in Table 1 .
To obtain the mrkI-complementation plasmids, the DNA fragment containing mrkI and its flanking regions was PCR-amplified from K. pneumoniae CG43S3 genomic DNA using primers wc07 and wc08, and the amplicon was cloned into yT&A (Yeastern Biotech) to yield pWY05. The mrkI coding region carried on pWY05 was then removed with inverse PCR using primers wc09 and wc10. Subsequently, the DNA fragment containing the mrkI region or the mrkI-flanking regions only were subcloned into pKAS46 to yield pWY45 and pWY28, respectively. The plasmids were then individually introduced into K. pneumoniae CG43S3 DmrkI via conjugation. The resulting transconjugants, with pWY28 and pWY45 integrated into the chromosome via homologous recombination, were designated CCW40 and CCW41, respectively.
Construction and expression of the recombinant proteins. The DNA fragments containing the coding sequences of MrkH, PilZ MrkH or MrkH N were individually PCR-amplified with primer pairs pcc212/pcc213, pcc335/pcc213 or pcc212/pcc336 and cloned into the expression vector pETQ to generate pMrkH, pPilZ or pMrkH N . The plasmids with site-directed mutations were constructed using inverse PCR. pMrkH was used as the PCR template to generate mutant allele-encoding MrkH R113D (MrkH*) recombinant proteins using primer pair pcc331/pcc332. The PCR product was resolved on an agarose gel, recovered, treated with DpnI for 2 h, and subjected to T4 polynucleotide kinase treatment and self-ligation. The ligation product was transformed into E. coli JM109. The plasmid pMrkH*, carrying the mutant allele encoding MrkH R113D , was prepared from the transformant colony and confirmed using sequence analysis. The DNA fragment encoding PilZ MrkH with the R113D mutation (PilZ*) was PCR-amplified with primer pair pcc335/pcc213, using pMrkH* as a template, and then cloned into pETQ to yield pPilZ*.
Western blot analysis. K. pneumoniae CG43S3 and its derived mutants were grown in LB broth with agitation at 37 uC. The bacterial cultures were collected by centrifugation and quantified with Bradford protein assays (Bio-Rad). The bacterial total protein, approximately 5 mg per lane, was then subjected to Western blot analysis using anti-MrkA antiserum. MrkA antiserum preparation and Western blot analysis were performed as described previously (Huang et al., 2009 ). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was probed using specific antiserum (GeneTex) as a loading control for the total lysates.
Biofilm formation assay. The ability of bacteria to form biofilm was analysed as described previously, with a minor modification (Lin et al., 2006; Wu et al., 2010) . Bacteria diluted 1 : 100 in LB broth supplemented with appropriate antibiotics were inoculated into each well of a 96-well microtitre dish (Orange Scientific) and statically incubated at 37 uC for 48 h. Planktonic cells were removed, and the wells were washed once with distilled water to remove unattached cells. Crystal violet (0.1 %, w/v, Sigma) was used for 30 min to stain the attached cells. Unattached dye was removed by washing three times with distilled water, and stained biomass was solubilized in 1 % (w/v) SDS. A 595 was determined and relative bacterial biofilmforming activities were calculated.
Measurement of promoter activity. The promoter regions of mrkA and mrkH were PCR-amplified with primer pairs pcc323/pcc324 and pcc319/pcc320, and the amplicons were then cloned into placZ15 (Lin et al., 2006) to generate pmrkA-P2 and pAW175, respectively. The promoter-reporter plasmids were individually mobilized into K. pneumoniae strains by conjugation from E. coli S17-1 lpir. The bacteria were grown to exponential phase in LB broth (OD 600 0.7) and the b-galactosidase activity was measured as described elsewhere (Lin et al., 2006) .
Quantitative RT-PCR (qRT-PCR).
Total RNAs were isolated from early exponential phase K. pneumoniae CG43S3 cells using an RNeasy Midi column (Qiagen) according to the manufacturer's instructions. Purified RNA was DNase-treated with RNase-free DNase I (MoBioPlus) to eliminate DNA contamination. RNA (1 mg) was reverse transcribed with a Transcriptor First Strand cDNA Synthesis kit (Roche) using random primers in a reaction mixture of 20 ml.
qRT-PCR was performed in a LightCycler 1.5 instrument (Roche). A LightCycler TaqMan Master kit (Roche) was used to detect mrkA (primers: GT29 and GT30; probe: 20), mrkH (primers: GT46 and GT47; probe: 120), mrkI (primers: GT31 and GT32; probe: 160), mrkJ (primers: GT54 and GT55; probe: 84) and 23S rRNA (primers: RT11 and RT12; probe: 67). These corresponding probes were selected using Universal Probe Library Assay Design Center (Roche Applied Science). Data were analysed using the software for the LightCycler 1.5 instrument. Relative gene expression was quantified using the comparative threshold cycle 2^D DCT method with 23S rRNA as the endogenous reference.
DNA electrophoretic mobility shift assay (EMSA). K. pneumoniae CG43S3 genomic DNA was used as a PCR template to amplify the P mrkA and P mrkH fragments F1, F2, F3 and F4 with primer pairs pcc323/pcc324, wcc54/pcc324, pcc319/pcc320 and pcc319/wcc55, respectively. The primers pcc323, pcc324, pcc319 and pcc320, each labelled with biotin at the 59 end, were used to amplify the F1* and (Lin et al., 2011) . The biotin-labelled DNA was detected with the LightShift chemiluminescent EMSA kit (Pierce).
Statistical methods. The results of the biofilm-forming and bgalactosidase activity assays were derived from a single experiment that represented three independent experiments. Each sample was assayed in triplicate and the data are presented as means (with SD). Differences between groups were evaluated with a two-tailed Student's t test. P values less than 0.001 were considered statistically significant.
RESULTS
MrkH and MrkI positively regulate the expression of type 3 fimbriae
As shown in Fig. 1(a) , RT-PCR analysis revealed that in addition to the coding region of mrkH, mrkI and mrkJ, the amplicons also include the junction of mrkH-mrkI and mrkI-mrkJ, indicating that the three genes could be transcribed as a single transcription unit. Nevertheless, the presence of an additional promoter for mrkJ expression, located in the 143 bp intergenic region between mrkI and mrkJ, was also demonstrated (Fig. 1b) . This implies that a different control is present for the expression of the c-di-GMP PDE activity of MrkJ, which modulates the c-di-GMP level, thereby differentially influencing type 3 fimbriae activity. This mechanism awaits further investigation.
Specific gene deletions of mrkH, mrkI and mrkJ in K. pneumoniae CG43, a highly virulent clinical isolate of the K2 serotype (Chang et al., 1996) , were constructed, and the derived mutants were analysed for the expression of type 3 fimbriae. As shown in Fig. 2(a) , type 3 fimbriae major pilin MrkA production was abolished in DmrkH and DmrkI mutants. Slightly increased MrkA production was observed for DmrkJ (approximately 1.67-fold), which is consistent with another report (Johnson & Clegg, 2010) . Moreover, the deletion effect of mrkI could be complemented, as MrkA production was restored in CCW41 carrying chromosomally integrated pKAS46-mrkI but not in CCW40, which carries a chromosomally integrated pKAS46 (Fig. 2a) .
Sequence analysis revealed that MrkH carries an N-terminal sequence of unknown function and C-terminal PilZ domain. As shown in Fig. 2(b) , by comparing this with the PilZ domain of YcgR (Ryjenkov et al., 2006) , the two conserved motifs and the critical residue for c-di-GMP binding could be identified. To investigate whether MrkH functions as a PilZ domain protein, the plasmids pMrkH*, carrying an R113D mutation on MrkH to impair c-di-GMP binding ability (Benach et al., 2007; Johnson et al., 2011; Ryjenkov et al., 2006) , pMrkH N , carrying N-terminal coding DNA (residues 1-108), pPilZ, carrying the PilZ domain (residues 85-237), or pPilZ* (PilZ MrkH carrying an R113D mutation) were constructed. As shown in Fig. 2(c) , the production of MrkA in DmrkH could also be restored by introducing pMrkH, which suggested a positive regulatory role for MrkH. The complementation effect was not observed after introduction of pMrkH*, pMrkH N , pPilZ or pPilZ* into DmrkH. This result indicated that the N terminus, the PilZ domain and the R113 residue of MrkH are required for MrkH-mediated control of type 3 fimbriae expression. Nevertheless, the results suggest that MrkH and MrkI also play positive roles in determining type 3 fimbriae expression.
MrkI autoactivates the transcription of mrkHI qRT-PCR analysis and promoter activity measurement were carried out to assess the effects of mrkH and mrkI deletion on the expression of type 3 fimbriae. As shown in Table 3 , the mrkA mRNA level decreased approximately three-and eightfold in DmrkH and DmrkI strains, respectively, indicating that MrkH and MrkI regulate type 3 fimbriae expression at the transcriptional level. Additionally, the mrkH transcript was found to diminish by 11-fold in response to mrkI deletion. The mrkI deletion effect could be complemented, as the mRNA levels of mrkA and mrkH in CCW41 increased about 10-fold when compared with those in CCW40, suggesting that MrkI positively regulates the expression of mrkHI at the transcriptional level. As shown in Fig. 2(d) , promoter activity measurement also revealed a decreased level of P mrkA caused by the deletion of mrkH or mrkI. Moreover, the promoter activity of mrkH was apparently decreased by mrkI deletion (Fig. 2d) , further supporting the possibility of auto-regulation by MrkI of the transcription of mrkHI. Conversely, the transcription of mrkJ was apparently unaffected by mrkH or mrkI deletion (Table 3) .
Fur positively regulates the expression of mrkHI
Sequence analysis of the putative promoter region of mrkH or mrkA revealed a 19 bp Fur box (Fig. 3a) . Although both Fur boxes show poor fits to the consensus (11/19), Furdependent regulation could not be excluded. To investigate this possibility, we performed qRT-PCR and promoter activity analyses. As shown in Table 3 , fur deletion apparently decreased the mRNA level of mrkH, mrkI and mrkA, and the introduction of a fur-carrying plasmid, pfur (Cheng et al., 2010) , into Dfur complemented the deletion effects. Reduced promoter activities of mrkA and mrkH were also observed in the Dfur mutant (Fig. 3b) . Moreover, MrkA production was abolished by the deletion of fur but could be restored by the introduction of pfur (Fig. 3c) . Biofilm formation in Dfur was reduced (by approximately 38 %) compared with that in the wild-type strain, and introduction of pfur into Dfur complemented the deletion effect (Fig. 3d) . These results indicate that Fur regulates mrkA and mrkHI expression and thereafter affects the activity of type 3 fimbriae.
Fur directly regulates the expression of mrkHI
EMSA was performed to analyse whether Fur directly affects the expression of mrkH or mrkA using the recombinant His 6 : : Fur protein and different DNA containing the putative promoter of mrkA and mrkH (Fig. 4a) . As shown in Fig. 4(b, c) , DNA-protein binding complexes were observed after the incubation of 250 nM purified His 6 : : Fur with 170 pM biotin-labelled P mrkA (F1*) or P mrkH (F3*). Both His 6 : : Fur-F1* and His 6 : : Fur-F3* bindings appeared to be specific, since their binding could only be competed by non-biotin-labelled F1 or F3 but not by a 2006 concentration of F2 or F4 DNA that had the Fur box removed (Fig. 4a) . Interestingly, F3, which contains a putative Fur-binding sequence, could readily outcompete the binding of His 6 : : Fur-F1* (Fig. 4b) . By contrast, His 6 : : Fur-F3* binding could not be inhibited by the addition of a 506 concentration of F1 (Fig. 4c) . This outcome indicated that Fur binds to the promoter of mrkHI with higher affinity than to the mrkA promoter. To analyse the effects of iron level on type 3 fimbriae activity, we grew CG43S3 in LB broth supplemented with increasing amounts of the iron chelator 2,29-dipyridyl (dipyridyl) and then analysed bacterial biofilm-forming activity. As shown in Fig. 5(a) , increasing amounts of dipyridyl apparently reduced biofilm formation capability. Iron salts, Fe(NH 4 ) 2 (SO 4 ) 2 and FeCl 3 , but not magnesium chloride, appeared to restore biofilm formation partially (Fig. 5b) , indicating that biofilm formation is influenced by iron concentration.
As shown in Fig. 5(c) , MrkA production was gradually reduced as increasing amounts of dipyridyl were added to the medium. Moreover, addition of Fe(NH 4 ) 2 (SO 4 ) 2 restored the production of MrkA in the iron-depleted medium (Fig. 5d) . No MrkA production was detected in Dfur under any of the growth conditions (data not shown), indicating that iron is a cue for the Fur-dependent expression of type 3 fimbriae.
DISCUSSION
The expression of fimbrial genes is usually controlled by adjacent genes encoding regulators, such as PapB/I for P fimbriae (Båga et al., 1985; Forsman et al., 1989; Hernday et al., 2002; Hultdin et al., 2010) , FimW/Y/Z for Salmonella type 1 fimbriae (Saini et al., 2009) and MrpJ for MR/P fimbriae (Lane et al., 2009; Li et al., 2001) . Consistent with the findings of Johnson et al. (2011) , we determined that type 3 fimbriae expression in K. pneumoniae CG43 is reduced by mrkH or mrkI deletion. We have also shown, however, that MrkI positively autoregulates the expression of mrkHI, which differs from the report on K. pneumoniae IApc35 (Johnson et al., 2011) . This discrepancy may result from differences in the bacterial strains or experimental methods used. Nevertheless, a negative role for mrkJ, which slightly increased MrkA expression in the DmrkJ mutant and the PDE activity of the recombinant His 6 : : MrkJ protein, was demonstrated (results not shown).
To investigate how MrkH affects the expression of type 3 fimbriae, we transformed DmrkI with pMrkH. As shown in Supplementary Fig. S2 , the introduction of pMrkH into DmrkI restored MrkA production, suggesting that MrkI activates the expression of type 3 fimbriae via MrkH functioning. Moreover, the induced expression of mrkH in Dfur, or DfurDmrkI, also restored the expression of type 3 fimbriae. These results imply a critical role for MrkH in this regulatory pathway.
In addition to the PilZ domain, which has recently been demonstrated to have c-di-GMP binding activity (Johnson et al., 2011) , the N-terminal region of unknown function was also required for MrkH regulatory activity. Previous reports have indicated that several PilZ domain proteins could bind to c-di-GMP and then perform their functions through protein-protein interactions (Boehm et al., 2010; Hengge, 2009) . In Xanthomonas, the binding among PilZ domain proteins, an ATPase (PilB) and an EAL domain protein Fig. 2 . Deletion effects of mrkH, mrkI and mrkJ on the expression of type 3 fimbriae. (a) K. pneumoniae strains (indicated above the image; WT, wild-type) were grown overnight at 37 6C with agitation in LB broth and subjected to Western blot analysis using MrkA antiserum. The fold change of MrkA amount calculated using ImageJ software (Girish & Vijayalakshmi, 2004 ) is shown. GAPDH was probed as a protein loading control. (b) Amino acid sequence alignment of PilZ domain proteins. Sequences of the PilZ domain proteins, including MrkH, PA3353, PP4397 and YcgR, were aligned with Vector NTI software. The conserved RxxxR motif and the D/NxSxGG motif are underlined (x, any residue). The critical residue involving in the c-di-GMP binding activity of YcgR is indicated by an arrow. (c) K. pneumoniae strains carrying expression plasmids (shown above the image) were grown in LB broth at 37 6C with agitation. When the bacterial growth reached mid-exponential phase, expression of the recombinant protein was induced by the addition of 0.5 mM IPTG and an additional 3 h of incubation. Western blot analysis was performed as described in Methods. (d) b-Galactosidase activities of K. pneumoniae CG43S3DlacZ (DlacZ) and its isogenic mrkH or mrkI deletion mutants (DlacZDmrkH or DlacZDmrkI) carrying the reporter plasmid pmrkA-P2 for P mrkA or pAW175 for P mrkH were determined using exponential phase cultures grown in LB broth. *P,0.001 compared with DlacZ. Table 3 . qRT-PCR analysis of the expression of mrk genes Deletion effects of mrkH, mrkI and fur on the expression of mrkA, mrkH, mrkI and mrkJ. ND, Not detected.
Gene
Expression ratio of mRNA (mean±SD) (Birck et al., 2002; Maris et al., 2002) or binding to ligands, including quorum-sensing molecules (Pappas et al., 2004; Schlegel et al., 2002) . Besides the C-terminal DNA-binding domain, an uncharacterized N-terminal domain is contained in MrkI and is probably involved in receiving signals. Sequence alignment of MrkI and other response regulators also revealed a conserved aspartate residue, which may act as a phosphorylation target, in the N terminus of MrkI ( Supplementary Fig. S3a ). To determine whether D56 played a role in MrkI-mediated regulation, D56A and D56E site-directed MrkI mutants were created. As shown in Supplementary Fig. S3(b) , a reduced production of MrkA in the D56A strain was observed. However, a slight decrease in MrkA was also found in the D56E strain. Hence, whether D56 phosphorylation of MrkI plays an important role in the regulation of type 3 fimbriae remains to be studied. Fig. S1 ) is marked as S1. The sequence of the upstream region of mrkH or mrkA and the alignment with the 19 bp Fur box (w5A or T) are shown. (b) b-Galactosidase activities of K. pneumoniae CG43S3DlacZ and its isogenic fur deletion mutant (DlacZDfur) carrying the reporter plasmid pmrkA-P2 for P mrkA (left) or pAW175 for P mrkH (right) were determined using exponential phase cultures grown in LB broth. *P,0.001 compared with DlacZ. (c) Anti-MrkA Western blot analysis. K. pneumoniae strains (indicated above the blot) were grown overnight at 37 6C with agitation in LB broth. Western blot analysis was performed as described in Methods. GAPDH was probed as a protein loading control. (d) Deletion of fur reduces bacterial biofilm formation. K. pneumoniae strains were grown at 37 6C for 48 h in LB, and bacterial biofilm formation was quantified as described in Methods. The mean of triplicate experiments is shown; error bars, SD.
Finally, we have shown that in addition to autoregulatory control by MrkI, the expression of mrkHI is positively regulated by Fur. The subsequent EMSA analysis indicated that Fur as a transcriptional activator directly activates the transcription of mrkHI. Fur may activate gene transcription by competing with the binding of other repressors to the target promoter (Carpenter et al., 2009; Nandal et al., 2010) . The possibility that another regulator(s) is involved in the Fur-activation of the mrkH promoter remains to be studied.
As shown in Fig. 3(a) , the occlusion of the MrkA transcription start site with the Fur box precludes direct regulation by Fur. Moreover, a single transcription start site, also identified in the most recent report (Wilksch et al., 2011) , was mapped for the MrkA transcripts isolated from the bacteria grown in LB, LB supplemented with 500 mM dipyridyl, M9, or M9 supplemented with 60 mM Fe(NH 4 ) 2 (SO 4 ) 2 ( Supplementary Fig. S1 ). This implies that Fur exerts an indirect regulation of type 3 fimbriae expression. The finding that the recombinant Fur bound to the mrkA promoter with much lower affinity compared with the binding activity to the mrkHI promoter (Fig. 4c) further supports indirect control of the type 3 fimbriae by Fur. Here, we propose that Fur influences the expression of type 3 fimbriae by positively regulating MrkHI expression and concurrently exerting a negative regulation of an unknown MrkA repressor (Fig. 6 ).
Although the Dfur mutant abolished MrkA production, we observed a relatively small reduction in biofilm formation in Dfur compared with that in DmrkA (Fig. 3d) . We have previously reported that K. pneumoniae CPS biosynthesis is activated in the Dfur mutant (Cheng et al., 2010) . Thus, we hypothesized that increased CPS on the bacterial surface may influence biofilm formation. Biofilm formation of E. coli has also been reported to be repressed under iron limitation, which is regulated by the Fe-S metalloregulatory protein IscR through control of type 1 fimbriae expression in a Fur-independent manner (Wu & Outten, 2009) . Although type 1 fimbriae have been shown not to participate in biofilm formation (Schroll et al., 2010) , whether IscR plays a role in K. pneumoniae biofilm formation remains to be studied. Fur has been implicated in iron uptake and metabolism, the oxidative stress response, colonization and virulence in many bacteria (Carpenter et al., 2009) . Reports of activity in iron-uptake systems (Lin et al., 2011) and CPS biosynthesis (Cheng et al., 2010; Lin et al., 2011) have been published, but this report is the first, to our (c, d) K. pneumoniae CG43S3 was grown in LB broth supplemented with dipyridyl and iron salts, as indicated. Western blot analysis was performed as described in Methods. GAPDH was probed as a protein loading control. Fig. 6 . Model of Fur control of type 3 fimbriae expression in K. pneumoniae. Upon ferric ion activation, Fur binds to the promoter region of mrkHI and the regulatory region of the not-yetidentified X repressor gene. The binding results in increasing expression of MrkH and MrkI, while reducing the X repressor expression. Subsequently, the increasing levels of MrkI act as a transcription activator and an autoactivator to activate the type 3 fimbriaeencoding operon mrkABCDF and mrkHI expression, while the reduced levels of X repressor release the suppression, which in turn increases type 3 fimbriae expression. In the presence of high MrkH and c-di-GMP levels, the MrkH-c-di-GMP complex exerts transcriptional activation of the mrkABCDF operon (Wilksch et al., 2011) .
knowledge, to demonstrate that Fur also participates in the regulation of type 3 fimbriae expression. In summary, the expression of type 3 fimbriae in K. pneumoniae CG43 is regulated by the availability of iron and is positively controlled by Fur. Because iron-uptake systems, CPS and type 3 fimbriae are well-known bacterial virulence factors, our findings substantiate the suggestion that Fur plays an important role in the regulation of K. pneumoniae pathogenicity.
